The ICIS Innovation Awards Winners 2022
LONDON, Nov. 8, 2022 /PRNewswire/ -- ICIS has revealed this year's ICIS Innovation Awards Winner is speciality chemical company, Evonik, for its sustainable rhamnolipid product REWOFERM® RL 100 that is revolutionising the laundry detergent market.
This prestigious award recognises those companies that show high levels of innovation in products and processes, as well as in digital innovation while also benefitting the environment and advancing progress towards sustainability.
Judges from sponsoring companies BASF, Accenture, Barentz, and Deloitte Consulting, together with NNFCC and ICIS reviewed over 75 entries for six innovation categories.
The winners are as follows:
Best Digital Innovation from a large company, Eastman Chemical - Fluid Genius - digital innovation for heat transfer fluid management.
Best Digital Innovation from a small-to-medium sized enterprise (SME), Electric Ant Lab - digital R&D solution that complements wet lab research.
Best Process Innovation from a large company - Clariant Catalysts and Technip Energies - reducing carbon footprint and enhancing operation in steam reforming with EARTH®.
Best Process Innovation from an SME - GreeNovel – a process for contaminated plastics recycling and metals extraction from e-waste using a developed chemical agent and microwave.
Best Product Innovation from a large company - Evonik Operations - REWOFERM® RL 100, this sustainable product is revolutionising the laundry detergent market.
Best Product Innovation from an SME - Genomatica – a new plant-based nylon-6 to slash GHGs from textiles, films and plastics that is advancing toward commercialisation.
ICIS chemical business deputy editor, Will Beacham, who chairs the judging panel, said: "With the global economy in turmoil, and the path to zero carbon high on the agenda, innovation has become even more important as a way to secure the planet and chemical industry's future. The ICIS Innovation Awards allows us to celebrate the industry's contribution to a sustainable future."
Johann-Caspar Gammelin, member of the executive board and president Nutrition and Care at Evonik said: "REWOFERM RL 100 demonstrates that we could use this innovative platform to solve various circularity challenges in our industry, such as biodegradability. As a specialty chemicals company, Evonik can make a big contribution to a liveable future: helping to curb climate change, limit the use of fossil raw materials and feed the growing world population."
Further information on the 2022 award winners can be found here: https://events.icis.com/ehome/innovationawards/Home/
About ICIS
ICIS is a trusted source of global commodity intelligence for the energy, chemical and fertilizer industry. We are a division of RELX, a FTSE 15 company with a market cap of £44 billion and an employee base of over 30,000 experts across 40 countries.
At ICIS, we help businesses make strategic decisions, mitigate risk, improve productivity, and capitalise on new opportunities. We make some of the world's most important markets more trusted and predictable by providing data services, thought leadership and decision tools. As a result of our unmatched global presence, we can deliver targeted connected intelligence to influence thousands of decisions across supply chains every single day. We shape the world by connecting markets to optimise the world's valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £44bn | €50.5bn | $50.5bn.
Share this article